1 / 6

TNT Study: Baseline Characteristics of the Patients

Explore baseline characteristics and lipid levels in patients from the TNT study, along with event rates against LDL cholesterol levels during statin therapy. Hazard ratio analysis on efficacy outcomes and insights on rhabdomyolysis presented. Findings published in the New England Journal of Medicine in 2005 by JC LaRosa.

joehernandez
Download Presentation

TNT Study: Baseline Characteristics of the Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TNT Study: Baseline Characteristics of the Patients JC LaRosa, N Engl J Med 2005; 352

  2. TNT Study: Mean Lipid Levels during the Study JC LaRosa, N Engl J Med 2005; 352

  3. TNT Study: Cumulative Incidence of a First Major Cardiovascular Endpoint JC LaRosa, N Engl J Med 2005; 352

  4. TNT Study: Estimated Hazard Ratio for the Components of the Primary and Secondary Efficacy Outcomes JC LaRosa, N Engl J Med 2005; 352

  5. TNT Study: Characteristics of Five Patients with Rhabdomyolysis JC LaRosa, N Engl J Med 2005; 352

  6. TNT Study: Event Rates Plotted against LDL Cholesterol Levels during Statin Therapy in Secondary-Prevention Studies JC LaRosa, N Engl J Med 2005; 352

More Related